June 1999
Volume 40, Issue 7
Free
Articles  |   June 1999
Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.
Author Affiliations
  • K Schmitz
    Eye Department, Otto-von-Guericke-University, Magdeburg, Germany.
  • P Banditt
    Eye Department, Otto-von-Guericke-University, Magdeburg, Germany.
  • M Motschmann
    Eye Department, Otto-von-Guericke-University, Magdeburg, Germany.
  • F P Meyer
    Eye Department, Otto-von-Guericke-University, Magdeburg, Germany.
  • W Behrens-Baumann
    Eye Department, Otto-von-Guericke-University, Magdeburg, Germany.
Investigative Ophthalmology & Visual Science June 1999, Vol.40, 1621-1624. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K Schmitz, P Banditt, M Motschmann, F P Meyer, W Behrens-Baumann; Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.. Invest. Ophthalmol. Vis. Sci. 1999;40(7):1621-1624.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

PURPOSE: To evaluate the concentration and kinetics of dorzolamide in the aqueous humor after its topical application. METHODS: Samples of aqueous humor were collected at the beginning of routine cataract surgery at defined intervals after topical application of a 2% solution of dorzolamide. After deep-frozen storage of the samples, drug extraction was achieved with a mixture of solvents. Quantification was carried out by high-performance liquid chromatography on a reversed-phase column. RESULTS: Peak concentrations of dorzolamide in aqueous humor were reached approximately 2 hours after application with 1000 ng/ml. Average values were approximately 1000 to 700 ng/ml after 4 to 6 hours and approximately 200 ng/ml after 12 hours. Mean half-life of absorption was 1.2 hours and for elimination 3.0 hours. CONCLUSIONS: Pharmacokinetics of dorzolamide in the aqueous humor of humans are in comparable dimensions as previously reported in experimental trials in pigmented rabbits. There is a clear linear absorption and elimination kinetic, which is demonstrated using the Bateman function. A better knowledge of the distribution and kinetics of dorzolamide will help to explain its reported effects on intraocular hemodynamics, distinct from its intraocular pressure lowering effect.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×